Suchergebnisse - "Asselah, Tarik"

PubPharm (409)

51

EASL-ALEH 2015 algorithm for the use of transient elastography in treatment-naive patients with hepatitis B : An independent validation

enthalten in: Journal of viral hepatitis | 2021

von Nana, J. | Skaare, K. | Bosson, J. | +5

52

Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Asselah, T. | Loureiro, D. | Le Gal, F. | +14

CommentIn: Liver Int. 2021 Jul;41(7):1441-1442. - PMID 34139064

53

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

enthalten in: JHEP reports : innovation in hepatology | 2021

von Ganne-Carrié, N. | Nahon, P. | Chaffaut, C. | +67

54

New therapies for hepatitis delta virus infection

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Loureiro, D. | Castelnau, C. | Tout, I. | +9

CommentIn: Liver Int. 2022 Jan;42(1):249-252. - PMID 34825765

55

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

enthalten in: Infectious diseases and therapy | 2021

von Aghemo, A. | Horsmans, Y. | Bourgeois, S. | +19

56

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

enthalten in: Infectious diseases and therapy | 2021

von Aghemo, A. | Horsmans, Y. | Bourgeois, S. | +19

57

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

enthalten in: Infectious diseases and therapy | 2021

von Aghemo, A. | Horsmans, Y. | Bourgeois, S. | +19

58

HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management

enthalten in: Cancer prevention research (Philadelphia, Pa.) | 2021

von Nahon, P. | Layese, R. | Cagnot, C. | +9

59

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies : A Real-World Experience in France

enthalten in: Digestive diseases and sciences | 2021

von Ouzan, D. | Larrey, D. | Guyader, D. | +49

60

Editorial : HBV cure-the quest for biomarkers to predict off-treatment sustained response

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Thibault, V. | Asselah, T.

CommentOn: Aliment Pharmacol Ther. 2021 Jan;53(2):314-320. - PMID 33222190